What you should know:
1. 23andMe will soon include information on genetic variants that can influence MUTYH-associated polyposis in its reports.
2. If customers opt-in to the report, 23andMe is providing an education module to help them interpret the results and understand the limitations of the report.
3. Hereditary CRC cases account for about 5 percent of all CRC cases, the company said.
4. Company CEO Anne Wojcicki said, “We are committed to giving people affordable and direct access to important health information that can impact their lives. We believe improved access to genetic testing and health information will help people engage in their own health.”
More articles on gastroenterology:
How ASC price transparency relates to value-based care, M&A activity & more: 4 insights
ACS grants Children’s Minnesota surgery center certification — 3 insights
HCA announces $1B public offering that could be used for acquisitions — 4 insights
